BARTSCH, HERBERT;ERKER, THOMAS, J. HETEROCYCL. CHEM., 25,(1988) N, C. 1399-1401
作者:BARTSCH, HERBERT、ERKER, THOMAS
DOI:——
日期:——
[EN] COMBINATION THERAPY COMPRISING A MAT2A INHIBITOR AND A TYPE II PRMT INHIBITOR<br/>[FR] POLYTHÉRAPIE COMPRENANT UN INHIBITEUR DE MAT2A ET UN INHIBITEUR DE PRMT DE TYPE II
申请人:[en]IDEAYA BIOSCIENCES, INC.
公开号:WO2022256806A1
公开(公告)日:2022-12-08
Provided herein is a combination product comprising a methionine adenosyltransferase II alpha (MAT2A) inhibitor and a Type II protein arginine methyltransferase (Type II PRMT) inhibitor. The combination product is useful for the treatment of a variety of cancers, including solid tumors. The combination product is useful for the treatment of any number of MAT2A-associated and/or PRMT-associated diseases.
Studies on the chemistry of O,N- and S,N-containing heterocycles.<b>4</b>. Investigations on the nucleophilic substitution of activated 1,5-benzothiazepines
作者:Herbert Bartsch、Thomas Erker
DOI:10.1002/jhet.5570250525
日期:1988.9
The reaction of the activated 1,5-benzothiazepine 1a with various amines is studied. In contrast to the phenylsubstituted derivative 1b no ring contraction but nucleophilic substitution is observed. Two novel ring systems8 and 9 are obtained by nitrosation of 3g and by reaction of 1a with anthranilic acid, respectively.